10-Hydroxycamptothecin (
HCPT) elicits strong anti-
cancer effects and is less toxic than
camptothecin (
CPT), making it widely used in recent clinical trials. However, its low solubility limits its application as an effective anti-
cancer therapy. In the present study we investigate the hypothesis that the unique water dispersible
oleic acid-Triton X-100-coated Fe3O4 nanoparticles loaded with
HCPT disrupt epithelial cell-cell junctions and induce human
lung cancer cell apoptosis through the
caspase-8 pathway. We characterized the
HCPT-loaded nanoparticles and determined their effects on
lung cancer cell viability and apoptosis by using immunofluorescence light microscopy and SDS-PAGE/immunoblots. We found that
HCPT-loaded nanoparticles elicited an anti-proliferative effect in a dose-dependent manner.
HCPT-loaded nanoparticles reduced the expression of cell-cell junction
protein claudins,
E-cadherin and ZO-1, and transmission electron microcopy demonstrated a disrupted tight junction ultrastructure. Transepithelial electric resistance was also reduced, indicating the reduction of tight junction functions. The
HCPT-loaded nanoparticles increased phosphorylation of p38 and SAPK/JNK while it showed no effects on p42/44 MAP
kinase. Compared with void Fe3O4 nanoparticles or
HCPT drug alone,
HCPT drug-loaded nanoparticles evoked synergistic effects by increasing cell apoptosis with enhanced activation of the
caspase-8 pathway. Therefore, our current study highlights the potential of
HCPT drug-loaded nanoparticles as a chemotherapeutic agent for increasing anti-
cancer drug efficacy.